Tenderwize
Zurück zur Suche

Open House Originale Agreement for Isavuconazole

Techniker Krankenkasse·Hamburg, Germany·Deadline Oct 30, 2027 · 432 days left·Open·Supplies
Registrieren zum SpeichernOpen documents
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-29 - Isavuconazol

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

62 / 100

Komplexität

56 / 100

Risikofaktoren

The notice states that offers/contracts cannot be submitted via the portal; submission must be by email with qualified...

Eligibility is limited to pharmaceutical undertakings for the relevant product with valid authorization and no exclusio...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Supply-side open-house rebate agreement for Isavuconazole.
  • Conclusion of rebate contracts under Section 130c(1) SGB V.
Vollständige Zusammenfassung anzeigen

Open-house supply arrangement by Techniker Krankenkasse for the pharmaceutical product Isavuconazole (CPV 33600000). The notice says all suitable pharmaceutical companies that meet the stated legal and self-declaration requirements may join during the contract period, with no exclusivity and no individual negotiation. Contract term is up to 24 months from 01.11.2025 to 31.10.2027, with possible automatic earlier end if patent/market exclusivity ends. No contract value is stated. Electronic submission via the tender portal is not allowed; contracts must be sent electronically by email with qualified electronic signature or by post. Procurement documents are available online, but no extracted document text beyond the notice was provided.

Risiken

The notice states that offers/contracts cannot be submitted via the portal; submission must be by email with qualified...

Eligibility is limited to pharmaceutical undertakings for the relevant product with valid authorization and no exclusio...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Participant must be a pharmaceutical company within the meaning of German medicinal products law for the relevant product.
  • Company seat must be in the scope of the AMG, another EU Member State, or another EEA state.
  • Valid marketing authorization for the relevant medicinal product and/or other right to place it on the market in own name.

Zuschlagskriterien

Lot 1

No explicit lot-specific award criteria provided; the notice indicates this is an open-house arrangement with uniform conditions.

Auftraggeber

Ort

Hamburg, DEU

Kennung

992-80116-93

Tätigkeit

Health

Lose (1)

LOT-0001

Open House Originale Agreement for Isavuconazole

Single lot for supply-side open-house rebate agreements for Isavuconazole with TK. Scope is nationwide in Germany. The lot information comes from structured notice data and the TED XML notice. No separate lot value is stated.

SuppliesEU fundedElectronic submission

Ort

DE600, Germany

Dauer

Oct 2025 - Oct 2027

Kategorie

Pharmaceutical products

Zuschlagskriterien

No explicit lot-specific award criteria provided; the notice indicates this is an open-house arrangement with uniform conditions.

Frist

Deadline Oct 30, 2027

Vergabedetails

Veröffentlichungsdatum
22 Sep 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
622464-2025

Dokumente (1)

Vergabedokument 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3